Assignee
HAEMALOGIX PTY LTD
AU·2 granted patents·4 pending applications·1 citations·filing 2016–2022
Top patents by PatentIndex Score
6 records- 0166US11305011B2Kappa myeloma antigen chimeric antigen receptors and uses thereofHAEMALOGIX PTY LTD·Filed 2016·Granted Apr 19, 2022·1 cites·18 claims
- 0260US2024262928A1Composition and MethodHAEMALOGIX PTY LTD·Filed 2021·Application pending·0 cites
- 0356US2022193232A1Kappa myeloma antigen chimeric antigen receptors and uses thereofHAEMALOGIX PTY LTD·Filed 2022·Application pending·0 cites
- 0451US11447571B2Anti-lambda myeloma antigen (LMA) binding proteins to treat LMA-expressing cancer and autoimmune disordersHAEMALOGIX PTY LTD·Filed 2019·Granted Sep 20, 2022·0 cites·6 claims
- 0547US2020255536A1Target for b-cell disordersHAEMALOGIX PTY LTD·Filed 2019·Application pending·0 cites
- 0639US2022031840A1Method of TreatmentHAEMALOGIX PTY LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HAEMALOGIX PTY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →